Lilly Announces Voluntary Delisting from Euronext Paris
Following the delisting from Euronext Paris, Lilly Shares will remain listed on the
A voluntary sales facility procedure on the
- decide not to participate in the voluntary sales facility and keep their Lilly Shares which they will be able to trade on Euronext Paris through and including the trading day prior to the delisting date and only on the
NYSE thereafter; or - participate in the voluntary sales facility described below and sell all or part of their Lilly Shares on the
NYSE .
Euronext Shareholders Not Participating
Euronext Shareholders who do not wish to sell their Lilly Shares under the sales facility, or otherwise have taken no action to tender their Lilly Shares in the sales facility, will be able to trade their Lilly Shares only on the
Participating Euronext Shareholders
Euronext Shareholders who wish to sell their Lilly Shares on the
The Lilly Shares delivered to BNP Paribas Securities Services will be sold on the
BNP Paribas Securities Services will calculate the average sale price of the Lilly Shares and will be in charge of transferring the sale proceeds to the participating Euronext Shareholders.
Lilly will pay the fees for the centralization and the brokerage fee related to the sale on the
Euronext Shareholders are reminded that they may tender their Lilly Shares in the sales facility on a voluntary basis.
No guarantee can be given by Lilly or by BNP Paribas Securities Services as to the price at which the Lilly Shares will actually be sold on the
The calendar of the sales facility and the delisting described above can be summarized as follows (it being specified that Lilly reserves the right to amend this calendar):
Sales Facility | |
Commencement of the sales facility procedure | 10/07/2019 |
Closing of the sales facility procedure | 10/18/2019 |
End of the centralization by BNP Paribas Securities | 10/23/2019 (before 4 p.m. Paris |
Sale of Lilly Shares tendered to the sales facility procedure | Beginning on 10/23/2019 |
Proceeds of sale in USD converted into Euros | As soon as possible after receipt |
Settlement of sale proceeds to relevant | As soon as possible after receipt |
Delisting | |
Last day of trading of Lilly Shares on Euronext Paris | 10/30/2019 |
Delisting of Lilly Shares from Euronext Paris | 10/31/2019 |
Euronext Shareholders participating in the sales facility procedure (i) acknowledge and agree to
assume the risks associated with changes in the market price of Lilly Shares and currency exchange rates that may occur between the time Lilly Shares are delivered to BNP Paribas Securities Services and the sale of such Lilly Shares on the
Lilly Shares will be delisted from Euronext Paris on
Lilly Shares will continue to be listed on the
Shareholders are invited to contact their financial intermediaries for any additional information.
About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com. F-LLY
Refer to: | Mark Taylor; mark.taylor@lilly.com; (317) 276-5795 (Media) |
Kevin Hern; hern_kevin_r@lilly.com; (317) 277-1838 (Investors) |
View original content to download multimedia:http://www.prnewswire.com/news-releases/lilly-announces-voluntary-delisting-from-euronext-paris-300930595.html
SOURCE